Adrenal disease

Metabolic Effects of Modified‐Release Hydrocortisone Versus Short Acting Conventional Oral Glucocorticoids in Adrenal Insufficiency: A Systematic Review and Meta‐Analysis

Clin Endocrinol (Oxf)Published Systematic review and meta-analysis

Authors' conclusion

MR-HC demonstrated improved effects on anthropometric measures, lipid profile, blood pressure, bone mineral density, and safety and tolerability compared to conventional GC with no apparent differences in glucose metabolism.

Study context

Population
Patients with adrenal insufficiency's (AI); comparative articles published until July 2025 (PubMed, Scopus, Web of Science)
Participants
400 patients6 studies
Comparison
Modified-release hydrocortisone (MR-HC) vs conventional glucocorticoid (GC)
Outcome
Glucose metabolism, anthropometrics, lipid profile and blood pressure
Methodological detailsprospectively registered
  • Prospectively registered

Pooled result

As reported in the abstract

Each group vs GCEstimate (95% CI)
MR-HC
MD (BMI) −1.1(−2.11 to −0.1)
MR-HC
MD (waist circumference) −5.03(−8.54 to −1.51)
MR-HC
MD (total cholesterol) −10.64(−19.86 to −1.42)
MR-HC
MD (systolic blood pressure) −6.03(−10.95 to −1.1)
MR-HC
MD (diastolic blood pressure) −4.35(−7.37 to −1.34)

Further pooled results

OutcomeEstimate
Bone health: lumbar spine and femoral neck T-scoreMR-HC vs GClumbar spine T-score 0.69 (95% CI 0.16–1.22)
Bone health: lumbar spine and femoral neck T-scoreMR-HC vs GCfemoral neck T-score 0.64 (95% CI 0.16–1.12)
AddiQol scoreNot favouring MR-HCAddiQol score 4.00 (95% CI −0.68 to 8.68)

Safety

OutcomeEstimate
Safety and tolerabilityMR-HC vs GCInfection score −1.7 (95% CI −2.6 to −0.8)
Safety and tolerabilityMR-HC vs GCflu-like events −1.0 (95% CI −1.6 to −0.4)
Safety and tolerabilityMR-HC vs GC · not favouring MR-HCvertebral fractures 0.20 (95% CI 0.03–1.55)

Original publication

Metabolic Effects of Modified‐Release Hydrocortisone Versus Short Acting Conventional Oral Glucocorticoids in Adrenal Insufficiency: A Systematic Review and Meta‐Analysis. Clin Endocrinol (Oxf). Published 28 April 2026. doi:10.1111/cen.70149

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.